A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
about
A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
@en
type
label
A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
@en
prefLabel
A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis
@en
P6153
P1050
P1476
A Randomized, Double-Blind, Pl ...... te-to-Severe Atopic Dermatitis
@en
P3098
NCT03443024
P580
2018-01-30T00:00:00Z
P582
2019-02-07T00:00:00Z